• 研究課題をさがす
  • 研究者をさがす
  • KAKENの使い方
  1. 課題ページに戻る

2013 年度 実施状況報告書

血管内皮増殖因子VEGF系を基軸とする、敗血症性多臓器不全の治療戦略の研究

研究課題

研究課題/領域番号 25462812
研究機関筑波大学

研究代表者

JESMIN Subrina  筑波大学, 医学医療系, 助教 (60374261)

研究期間 (年度) 2013-04-01 – 2016-03-31
キーワード医学 / 外科系臨床医学 / 救急医学 / 集中治療学 / 敗血症
研究概要

From previous several studies of our and other research groups, now we know vascular endothelial growth factor (VEGF) and its signaling cascade play a key central role in pathogenesis of multiple organ dysfunction syndromes in sepsis (MODS) of both animals and humans. Last year, we examined several drugs in sepsis animals to check whether the aberrant expression of VEGF in several important organs can be reversed and normalized in context of dose and time dependent manners. VEGF is significantly downregulated in sepsis animals in lung tissues and plays an important role in the pathogenesis of lung injury in sepsis. Blockade of protease activated receptor-2 normalized the downregulated pulmonary VEGF expression in sepsis rat models at early time points. In addition, the blockade of TNF-alpha in septic rats for three hours also significantly reversed the decreased pulmonary VEGF expression. These results establish a link between coagulation/fibrinolytic pathways with inflammatory mediators in the pathogenesis of lung injury in sepsis in context to the aberrant pulmonary VEGF expression. Like lung tissues, in septic heart at early hours, we also found decreased level of VEGF expression with altered hemodynamics. Treatment with landiolol, a selective ultra short acting beta blocker for three hours significantly reversed the decreased VEGF expression in heart tissues in sepsis. Thus, we state that TNF-alpha, protease activated receptor-2 and beta adrenergic receptors may have roles in regulating the expression of VEGF in heart and lung tissues at early hours of sepsis.

現在までの達成度 (区分)
現在までの達成度 (区分)

1: 当初の計画以上に進展している

理由

The current research is on right track both from the contexts of time line and the amount of research activities scheduled to be done (100% done with target milestone achievement). Last year, we used five types of pharmacological drug interventions (protease activated receptor blockade-2, TNF-alpha blockade, landiolol hydrochloride treatment, dual endothelin blockade, recombinant VEGF therapy) in sepsis animals at various time points with various doses and systematically checking the effects of those drug treatments on VEGF expression in important sepsis-induced organ dysfunction (lung, heart, kidney, liver, brains). We investigated in depth both protein and gene expression of target molecules to be assessed in the present study with respective organ function and morphology. We also generated ARDS models by saline lavage in rabbit and determined the expression of VEGF in lung tissues with inflammatory cytokines. We made animal models of sepsis of longer duration and generated survival curves in context to various drug treatments. We studied the relation of VEGF with altered hemodynamic state in sepsis at both compensatory and decompensatory phases. Besides, we generated acute and chronic models of sepsis and examined the organ specific expression of VEGF in relation to organ morphology and organ dysfunction. In addition, organ specific VEGF expression has also been studied in several animal models of sepsis namely mouse, rat and rabbit models. We also made the diabetic animals and then induced sepsis in diabetic models at pilot study level.

今後の研究の推進方策

We already used several pharmacological approaches to reverse the organ specific VEGF expression alteration in sepsis of several duration and doses. Last year we mainly concentrated to lung and heart tissues in septic models. Now we are systematically investigating the effects of several drug treatments on VEGF expression in liver, kidney and brain tissues in sepsis. Based on our data on endothelin blockade in sepsis models, we also tend to investigate whether endothelin blockade has any role in regulating VEGF expression in several organs in sepsis. In addition, this year brain, heart, lung, liver and kidney tissues will be taken out from both septic animal with or without drug treatment, including control animal samples and will be used for RNA isolation and microarray analysis, and ultimately identification of the differentially expressed genes. Determination of common gene expression signature, validation of common gene signature by real-time PCR, and bioinformatics analysis (functional, ontology, biological process, clustering, pathways and network analysis) will be also performed. We will also establish a technique to visualize the microcirculation in kidney tissues in sepsis. In addition, as VEGF plays crucial roles in organ dysfunction in both sepsis and diabetes, now we are also generating diabetic sepsis models and organ specifically checking whether diabetes can be an aggravating factor in alteration of VEGF expression in septic organs. This year we will produce sepsis models in genetically manipulated animals and will investigate organ specific VEGF expression.

次年度の研究費の使用計画

Last year we could not buy some VEGF-related pharmacological drugs of high costs, so we had some money unused from last year.
This year we will use that unused money from last year to treat sepsis models with VEGF-related expensive drugs.

  • 研究成果

    (22件)

すべて 2014 2013 その他

すべて 雑誌論文 (8件) (うち査読あり 8件、 オープンアクセス 1件、 謝辞記載あり 1件) 学会発表 (14件) (うち招待講演 1件)

  • [雑誌論文] Effects of protease activated receptor (PAR)2 blocking peptide on endothelin-1 levels in kidney tissues in endotoxemic rat mode.2014

    • 著者名/発表者名
      Jesmin S, Shimojo N, Yamaguchi N, Mowa CN, Oki M, Zaedi S, Sultana SN, Rahman A, Islam M, Sawamura A, Gando S, Kawano S, Miyauchi T, Mizutani T.
    • 雑誌名

      Life Sci.

      巻: 102 ページ: 127-133

    • DOI

      10.1016/j.lfs.2014.03.013.

    • 査読あり / オープンアクセス / 謝辞記載あり
  • [雑誌論文] Significant reversal of cardiac upregulated endothelin-1 system in a rat model of sepsis by landiolol hydrochloride.2014

    • 著者名/発表者名
      Seki Y, Jesmin S, Shimojo N, Islam MM, Rahman MA, Khatun T, Sakuramoto H, Oki M, Sonobe A, Kamiyama J, Hagiya K, Kawano S, Mizutani T.
    • 雑誌名

      Life Sciences

      巻: S0024-3205(14) ページ: 00405-6

    • DOI

      10.1016/j.lfs.2014.04.005.

    • 査読あり
  • [雑誌論文] Assessment of circulatory and pulmonary endothelin-1 levelsin a lavage-induced surfactant-depleted lung injury rabbit model with repeated open endotracheal suctioning and hyperinflation.2014

    • 著者名/発表者名
      Kamiyama J, Jesmin S, Sakuramoto H, Shimojo N, Islam MM, Khatun T, Oki M, Kawano S, Mizutani T.
    • 雑誌名

      Life Sciences

      巻: S0024-3205(14) ページ: 00401-9

    • DOI

      10.1016/j.lfs.2014.04.001.

    • 査読あり
  • [雑誌論文] The role of angiogenic factors and their soluble receptors in acute lung injury (ALI)/ acute respiratory distress syndrome (ARDS) associated with critical illness.2013

    • 著者名/発表者名
      Wada T, Jesmin S, Gando S, Yanagida Y, Mizugaki A, Sultana SN, Zaedi S, Yokota H.
    • 雑誌名

      Journal of Inflammation (Lond)

      巻: 10(1) ページ: 6

    • DOI

      10.1186/1476-9255-10-6.

    • 査読あり
  • [雑誌論文] The dynamics of angiogenic factors and their soluble receptor in relation to organ dysfunction in disseminated intravascular coagulation associated with sepsis.2013

    • 著者名/発表者名
      Jesmin S, Wada T, Gando S, Sultana SN, Zaedi S.
    • 雑誌名

      Inflammation

      巻: 36(1) ページ: 186-96

    • DOI

      10.1007/s10753-012-9534-6.

    • 査読あり
  • [雑誌論文] Normal prothrombinase activity, increased systemic thrombin activity, and lower antithrombin levels in patients with disseminated intravascular coagulation at an early phase of trauma: Comparison with acute coagulopathy of trauma-shock.2013

    • 著者名/発表者名
      Yanagida Y, Gando S, Sawamura A, Hayakawa M, Uegaki S, Kubota N, Homma T, Ono Y, Honma Y, Wada T, Jesmin S.
    • 雑誌名

      Surgery

      巻: 154(1) ページ: 48-57

    • DOI

      10.1016/j.surg.2013.02.004

    • 査読あり
  • [雑誌論文] Coagulofibrinolytic changes in patients with disseminated intravascular coagulation associated with post-cardiac arrest syndrome- Fibrinolytic shutdown and insufficient activation of fibrinolysis lead to organ dysfunction.2013

    • 著者名/発表者名
      Wada T, Gando S, Mizugaki A, Yanagida Y, Jesmin S, Yokota H, Ieko M.
    • 雑誌名

      Thrombosis Research

      巻: 132(1) ページ: e64-9

    • DOI

      10.1016/j.thromres.2013.05.010

    • 査読あり
  • [雑誌論文] Repeated open endotracheal suctioning causes gradual desaturation but does not exacerbate lung injury compared to closed endotracheal suctioning in a rabbit model of ARDS.2013

    • 著者名/発表者名
      Sakuramoto H, Shimojo N, Jesmin S, Unoki T, Kamiyama J, Oki M, Miya K, Kawano S, Mizutani T.
    • 雑誌名

      BMC Anesthesiology

      巻: 13(1) ページ: 47

    • DOI

      10.1186/1471-2253-13-47.

    • 査読あり
  • [学会発表] LPS誘発性敗血症ラットモデルに於ける臓器特異的VEGF発現2014

    • 著者名/発表者名
      Jesmin S, Sonobe A, Wada T, Shimojo N, Gando S, Kawano S, Mizutani T
    • 学会等名
      第41回日本集中治療医学会
    • 発表場所
      京都市
    • 年月日
      20140227-20140301
  • [学会発表] 敗血症マウス前頭葉における炎症性サイトカイン発現の経時的変化の解析2014

    • 著者名/発表者名
      Sonobe A, Jesmin S, Shimojo N, Kawano S, Mizutani T
    • 学会等名
      第41回日本集中治療医学会
    • 発表場所
      京都市
    • 年月日
      20140227-20140301
  • [学会発表] エンドセリン両受容体遮断薬は敗血症モデルラットの活性化したVEGF血管新生シグナルを増強する2014

    • 著者名/発表者名
      Ooki S, Jesmin S, Shimojo N, Hagiya K, Yamasaki Y, Kawano S, Mizutani T
    • 学会等名
      第41回日本集中治療医学会
    • 発表場所
      京都市
    • 年月日
      20140227-20140301
  • [学会発表] ショックの全身管理に伴う凝固薬の併用と使用基準の検討.2014

    • 著者名/発表者名
      Miya K, Shimojo N, Hagiya K, Sakuramoto H, Unoki K, Jesmin S, Kawano S, Mizutani T
    • 学会等名
      第41回日本集中治療医学会
    • 発表場所
      京都市
    • 年月日
      20140227-20140301
  • [学会発表] Effects of landiolol hydrochloride, an ultra-short-acting β-blocker, on cardiac endothelin system in a rat model of endotoxemia: a possible relevance with cardiac functional compensatory events at the early phase of sepsis2013

    • 著者名/発表者名
      Seki Y, Jesmin S, Shimojo N, Islam M, Khatun T, Sakuramoto H, Kamiyama J, Hagiya K, Kawano S, Mizutani T
    • 学会等名
      The Thirteenth International Conference on Endothelin
    • 発表場所
      東京
    • 年月日
      20130908-20130911
  • [学会発表] Dual endothelin blockade exacerbates upregulated VEGF angiogenic signaling in the heart of lipopolysaccharide -induced endotoxemic rat model2013

    • 著者名/発表者名
      Oki M, Jesmin S, Shimojo N, Islam M, Khatun T,Kawano S, Mizutani T
    • 学会等名
      The Thirteenth International Conference on Endothelin
    • 発表場所
      東京
    • 年月日
      20130908-20130911
  • [学会発表] Upregulated pulmonary endothelin-1 in acute lung injury is not normalized through landiolol hydrochloride treatment, an ultra-short-acting β-blocker, in a rat model of endotoxemia2013

    • 著者名/発表者名
      Shimojo N, Jesmin S, Seki Y, Sakuramoto H, Islam M, Khatun T, Kawano S, Mizutani T
    • 学会等名
      The Thirteenth International Conference on Endothelin
    • 発表場所
      東京
    • 年月日
      20130908-20130911
  • [学会発表] Effects of repeated closed vs. open endotracheal suctioning during mechanical ventilation on the pulmonary and circulatory levels of endothelin-1 in a lavage induced surfactant depleted rabbit ARDS model2013

    • 著者名/発表者名
      Sakuramoto H, Jesmin S, Shimojo N, Kamiyama J, Islam M, Khatun T, Kawano S, Mizutani T
    • 学会等名
      The Thirteenth International Conference on Endothelin
    • 発表場所
      東京
    • 年月日
      20130908-20130911
  • [学会発表] Blood pressure independent downregulation of plasma endothelin-1 levels in a lavage-induced surfactant depleted rabbit ARDS model: Effects of various respiratory maneuvers on endothelin-1 levels2013

    • 著者名/発表者名
      Kamiyama J, Jesmin S, Sakuramoto H, Islam M, Khatun T, Shimojo N, Kawano S, Mizutani T
    • 学会等名
      The Thirteenth International Conference on Endothelin
    • 発表場所
      東京
    • 年月日
      20130908-20130911
  • [学会発表] Potential amelioration of upregulated renal HIF1alpha-Endothelin 1 system through landiolol hydrochloride in a rat model of endotoxemia: a possible linkage to the increased renal vascular resistance based on renal microcirculation alteration in sepsis2013

    • 著者名/発表者名
      Ogura Y, Shimojo N, Jesmin S, Seki Y, Sakuramoto H, Hagiya K, Kawano S, Mizutani T
    • 学会等名
      The Thirteenth International Conference on Endothelin
    • 発表場所
      東京
    • 年月日
      20130908-20130911
  • [学会発表] Concomitant downregulation of ET-1-ETB system and VEGF angiogenic signaling in the frontal cortex of a murine model of endotoxemia: A double threat to cerebral microcirculation in sepsis2013

    • 著者名/発表者名
      7. Sonobe A, Jesmin S, Shimojo N, Islam M, Khatun T, Oki M, Kawano S, Mizutani T
    • 学会等名
      The Thirteenth International Conference on Endothelin
    • 発表場所
      東京
    • 年月日
      20130908-20130911
  • [学会発表] The Dynamics of Angiogenic Factors and Their Soluble Receptors in Relation to Organ Dysfunction in Disseminated Intravascular Coagulation Associated with Sepsis.2013

    • 著者名/発表者名
      Jesmin S, Shimojo N, Wada T, Kawano S, Gando S, Mizutani T
    • 学会等名
      第22回日本集中治療医学会関東甲信越地方会
    • 発表場所
      茨城県つくば市
    • 年月日
      20130823-20130824
  • [学会発表] ole of angiogenic growth factors in post cardiac arrest syndrome.2013

    • 著者名/発表者名
      Shimojo N, Jesmin S, Wada T, Kawano S, Gando S, Mizutani T
    • 学会等名
      第22回日本集中治療医学会関東甲信越地方会
    • 発表場所
      茨城県つくば市
    • 年月日
      20130823-20130824
  • [学会発表] Organ specific differential effect of landiolol hydrochloride, an ultra-short-acting β-blocker, on endothelin system in an animal model of sepsis: A new horizon of exploring the therapeutic potential of target molecule based drug innovation in sepsis

    • 著者名/発表者名
      Jesmin S
    • 学会等名
      Annual Research Meeting Sponsored by Ono Pharmaceuticals
    • 発表場所
      茨城県つくば市
    • 招待講演

URL: 

公開日: 2015-05-28  

サービス概要 検索マニュアル よくある質問 お知らせ 利用規程 科研費による研究の帰属

Powered by NII kakenhi